Edgewise Therapeutics, Inc. (EWTX) stock

EWTXNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 8/30

$45.93+0.11 (+0.24%)

Close on Nov 13, 2026Market cap $4.99BP/E 5.6Yield –

Edgewise Therapeutics gross margin

Gross margin is gross profit as a percentage of revenue.

Edgewise Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?